Antibiotics That Cause Altered Mental Status
Beta-lactam antibiotics, particularly cefepime and cefazolin, are the most notorious for causing altered mental status, with fluoroquinolones, macrolides, and antivirals (especially acyclovir) also being significant culprits.
High-Risk Beta-Lactams (Ranked by Neurotoxicity)
The 2019 French Society guidelines provide a clear hierarchy of beta-lactam neurotoxicity 1:
Most Neurotoxic:
- Cefazolin (294× more convulsive than penicillin G)
- Cefepime (160× more convulsive than penicillin G)
- Penicillin G (baseline reference = 100)
- Imipenem (71× relative activity)
Moderate Risk:
- Aztreonam (42×)
- Ampicillin (21×)
- Ceftazidime (17×)
- Meropenem (16×)
Lower Risk:
- Ceftriaxone (12×)
- Piperacillin (11×)
- Cefotaxime (8.8×)
- Cefoxitin (1.8×)
Clinical Manifestations
Beta-lactam neurotoxicity presents as 1:
- Acute confusional state
- Encephalopathy
- Myoclonus
- Seizures and status epilepticus (potentially fatal)
Critical Risk Factors
Renal failure is the primary risk factor for antibiotic-induced AMS, causing rapid drug accumulation 1. Even with appropriate renal dosing, cefepime neurotoxicity still occurs in 26% of cases 1.
Toxic Threshold Concentrations
Specific trough levels associated with 50% neurotoxicity risk 1:
- Cefepime: >22 mg/L (intermittent) or >35 mg/L (continuous infusion)
- Meropenem: >64 mg/L
- Flucloxacillin: >125 mg/L
- Piperacillin alone: >360 mg/L
- Piperacillin/tazobactam: >157 mg/L (97% specificity, 52% sensitivity)
Other High-Risk Antibiotics
Fluoroquinolones (particularly ciprofloxacin) cause neuropsychiatric effects ranging from anxiety and confusion to psychosis 2, 3, 4.
Acyclovir causes AMS especially in patients with chronic kidney disease, even when prescribed for common conditions like herpes zoster 5. The case literature demonstrates progressive confusion and ataxia that resolves with dialysis.
Macrolides are noted in drug-drug interaction warnings for potential CNS effects 2.
Trimethoprim-sulfamethoxazole requires caution in patients with reduced kidney function, particularly when combined with ACE inhibitors or ARBs 2.
Management Algorithm
Suspect antibiotic neurotoxicity in any patient with unexplained neurological manifestations, especially with renal impairment 1
Immediately consider:
For confirmed toxicity:
Critical Pitfall
Do not automatically treat pyuria with antibiotics in patients presenting with AMS 6, 7. The IDSA recommends against treating asymptomatic bacteriuria in patients with AMS, as this leads to missed alternative diagnoses and unnecessary antibiotic exposure without improving outcomes.
The 2019 guidelines emphasize that exceeding plasma concentrations >8× the MIC is "useless and even dangerous" for beta-lactams without validated toxicity thresholds 1.